“Major Announcement Due by March 31” — What’s the “Bionic Surgeon” Looking for imminent FDA Approval?

Ernie Tremblay says this "Imminent Decision" will "unlock massive $18 billion market" and "spark a 224,00% sales surge for a $2 Microcap"

By Travis Johnson, Stock Gumshoe, March 8, 2016

This ad first showed up in our inboxes under the “end surgery forever” headline in late January, and the following article first appeaered on January 26.

We have not gone through and updated the article, though the basic pitch is just about the same in the new version of the ad today as it was then. The “Major Announcement” is getting a bit closer, because the Company has consistently said they expect to hear a response from the FDA in the first quarter (and that ends on March 31).

Whether or not this widely-expected response from the FDA will have an immediate positive impact on the shares, I don’t know. The odds of approval seem quite high, I have not seen any analysts predict that they’ll fail to get approval this time … though there was also a sharply worded short attack on the shares from TheStreetSweeper a couple weeks ago. You can read the comments following the article for some of those updates and reactions along the way, but the rest of this article is unchanged from when it first appeared here six weeks ago:

“Intuitive Surgical’s stock price bolted from $3 all the way to $561 a share today.

“That’s a 19,000% return…

“Good enough to turn $10,000 into $1.9 million…

“And yet, it’s just a glimpse of the gains coming down the pike right now.

“You see, as innovative and groundbreaking as da Vinci is…

“Keep in mind, it’s not perfect.

“And the $2 company I’m recommending today has the patented technology to take robotic surgery to the next level…”

That’s what caught some of our readers’ eyes from a recent Ernie Tremblay ad — he’s looking for new subscribers to his Biotech Insider Alert, and in order to entice you he’s hinting about the “next Intuitive Surgical.”

That’s like waving a sausage in front of a dog, we can’t help but keep following — every investor is enchanted with the idea of finding the next mega-growth stock like Intuitive Surgical (ISRG) and their da Vinci machine. Even those of us dummies who sold the stock $400 ago (don’t ask).

So what’s this new technology? More from Tremblay:

“Their new technology isn’t just a tool used by a surgeon…

“It merges with the surgeon…

“Creating a whole new reality. Part man. Part machine.

“In short, a ‘bionic surgeon.'”

Cue the obligatory references to the Six Million Dollar Man (or, inflation adjusted, the $22 Million Man), but what Tremblay is touting here is a company with some sort of next-level surgical robot system, an improvement over Intuitive Surgica’s da Vinci.

More clues:

“… it’s moved through the FDA approval process while attracting some of the savviest technology investors on the planet, including a billionaire often referred to as the ‘Warren Buffet of biotech….’

“… you need to understand that in the coming weeks, this breakthrough bionic surgeon could hit every hospital and surgical center on the planet.”

“In the coming weeks?” Be serious. Even if this weren’t a half-million-dollar machine it would take time to roll out and build to critical scale.

Some of the biotech-savvy among you have already guessed what stock this is, I imagine, but don’t ruin the surprise for everyone else…

let’s check out some more clues:

“Surgeons ‘wear’ the technology and are always in the same room conducting the surgery themselves.

“If there’s a problem, the surgeon is right there next to the patient – inside the sterile field – able to respond immediately.

“This is crucial. One surgeon puts it this way:

‘If you’re sitting on a console 10 feet away, you’re not scrubbed in. If there’s catastrophe on the field the first thing you have to do is: somebody has to undock the unit… Then you have to move the entire apparatus off the field while you run outside and scrub. If you think about the amount of time it takes to do that, it might be a few minutes, but it’s a lifetime literally to that patient.’

“Problems like these won’t happen with this new technology.”

I don’t know that this is a particularly big problem with the da Vinci, it’s not like the patient is alone in the room with the machine while the doctor’s across campus. But that’s beside the point, more clues:

“…. the Bionic Robot gives surgeons an intimate feel for what they are doing….

“It’s almost like they are wearing bionic surgical gloves.

“They can actually ‘feel’ what they are doing, adding human sensibilities that a robot alone could never deliver.

“Here’s how Dr. Juan-Carlos Verdeja – Director of Surgery at Baptist Health – describes this game-changing benefit…

‘It has the opportunity to revolutionize the robotic market. The platform allows me to scrub in and work at the patient’s side, and maintains a tactile feel that I want as a surgeon.'”

That has been a complaint, sometimes, about Intuitive Surgical — their robot doesn’t have the “haptic” touch feedback that surgeons would prefer.

And yes, this is another kind of laparoscopic surgery — minimally invasive, like conventional laparoscopy or the da Vinci, the tools and camera go through a small incision (or incisions) and the surgeon performs his (or her) maneuvers under the skin. More from the ad:

“The surgeon makes a small, single incision – often hidden in the patient’s belly button.

“He then inserts a small tube which opens up like an umbrella, delicately positioning tiny surgical instruments inside the patient.

“The surgeon controls the instruments with his hands, all the while watching through a ‘bionic eye’ via a high definition camera.”

And more on that cost differential Tremblay noted:

“Intuitive Surgical’s da Vinci robot is priced as high as $2 million, putting it out of reach for most hospitals.

“You might expect this next-generation Bionic Surgeon to be even more expensive…

“I mean, it’s such a drastic improvement, a higher price – even as high as $3.5 million or more – would be justified.

“But it’s not more expensive…

“In fact, this tiny $2 company’s breakthrough Bionic Surgeon is 75% LESS than Intuitive Surgical’s da Vinci robot.

“That’s right. While the da Vinci robot can cost $2 million, the Bionic Surgeon will only cost around $500,000.”

Who is it? Here they’re teasing TransEnterix (TRXC), which is a very small company ($180 million market cap, looks like they have plenty of cash) that’s been acquiring other small robotic technology companies in recent years and developing what is, to some extent, a da Vinci competitor.

The machine Tremblay’s mostly referring to is the SurgiBot, which is a smaller, one-port laparoscopy machine, but they also did recently acquire the Italian company behind the Alf-X, which is a multi-port laparoscopy robot that seems more similar to the big da Vinci. The SurgiBot is currently with the FDA for review and TransEnterix expects clearance within the next few months (the general expectation is 6-9 months from submission, and they submitted the application for approval in June).

And our own Dr. KSS went into quite a bit of detail on TransEnterix over the Summer, so I’ll just let you go over and read his article for more background (the stock ha also been discussed pretty widely in the discussion sections of Dr. KSS’s other articles). I don’t have an opinion on this one, though the space seems more competitive now than it was when Intuitive Surgical was getting started — but I wanted to get this teaser solution out to you quickly instead of spending a few hours looking at the stock, but it has sure come down in price in these weeks leading up to possible (likely, most folks seem to think) approval.


Irregulars Quick Take Paid members get a quick summary of the stocks teased and our thoughts here. Join as a Stock Gumshoe Irregular today (already a member? Log in)

152
Share your thoughts...

avatar
58 Comment threads
94 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
70 Comment authors
Uncle AlbertEricLisettejimppcAman Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Max
Guest
Max

When you buy stocks in the middle of a major bear market you are most likely to get burned. Now is the time to eschew any and all buy recommendations until the bear is finished. Yes, I know there are always a tiny percentage of stocks that up during a bear market. And a particular sector might end its downtrend earlier than the rest. But right now we’ve a long way to go before it’s over.

Opposeablethumb
Member

Yes, one should always ignore items on sale at a good price and wait until the price rises.
Depressed by this market? I am exhilarated!

bill897
Member
bill897

When there’s blood in the street. That’s when you buy and hold. Because you are buying at depressed prices, providing you buy the right stock for the right reasons. Buffet usually buys 25% in a company, gets to know the management, gains inside information that is not public knowledge, then: just like Icahn bought Netflix: got inside information, got a board seat, pushed the company higher when it was a 500 stock and all the hedge funds followed him into that stock; then he got out after making billions and now Netflix is barely 100. I believe that’s the way… Read more »

Add a Topic
5971
Add a Topic
342
Add a Topic
5971
mike mills
Guest
mike mills

Netflix had a 7-1 stock split last year – that’s why it’s in the $100/sh range now.

Add a Topic
342
Add a Topic
5971
arch1
Member

Mike You are correct. Many companies like to keep the price of their stock at not much over $100.00 Part of the reason is that options are traded in blocks of 100 shares,
and where someone might lay out $10,000.00 for a trade they might be hesitant to place $70,000.00 at risk for a trade that may only return a few hundred$$$.

Add a Topic
5971
Add a Topic
570
Normally Dubious
Guest
Normally Dubious

That $2 stock is now a $4 stock and those who bought early have already doubled, despite your bearish outlook.

Add a Topic
5971
Add a Topic
5971
Norma
Guest
Norma

How do you know? .. What is the stock code of the $2 stock that is now a $4 stock? .. I’d like to check into it more. – Thanks!

Add a Topic
5971
Add a Topic
5971
Add a Topic
5971
sjanus11
Member
sjanus11

Norma, It’s TRXC
FDA Decision y the end of March. I’m in at about 3.75 and long

Add a Topic
3022
Uncle Albert
Guest
Uncle Albert

sjanus11, ditto for me on both counts

sjanus11
Member
sjanus11

Uncle Albert, I’ve spent 2 weeks doing D&D and this Co. and for the life of me I’ve come to the conclusion it is a “Once in a life time” opportunity. FDA approval could come anytime this week. It should go thru as one of the team has 9 yrs experience working FDA doing just that. Examining the 501k’s for approval. FDA would love comp in market. There management team is stellar. 2 new platforms with “Haptic” which Da Vinci does not have. Market at about 2 Billion now, and projected to go to around 10 Billion in around 4-5… Read more »

Add a Topic
3022
Add a Topic
3022
Add a Topic
3022
Uncle Albert
Guest
Uncle Albert

On 3/07/2016, I bought 2000 shares of TRXC at $4.09…missed the run-up to $5.00 but saw the the most recent activity and put in a sell order lat week at $4.90 which would be 20% gain which was executed this week…had been severely underwater with this stock for the past two years so was ecstatic to get out with a 20% gain…have told my wife that it is not a loss until I sell it

Add a Topic
5971
MM
Guest
MM

Think that the stock may have been CPXX, up almost 400% today on Leukemia drug news

Add a Topic
5971
Gr8Full!
Member

$CPXX-MM, not a chance. Suggest avoiding retch and puke. Immuno-Onc far exceeds science. Learn more via ZKSS and the biotech team. 13 1/2 cents per day is the best investmest I have ever made 4 StockGumShoe.com Best2You-Ben

barndoor
Member
barndoor

Travis – or anyone – do you think that Biotech Insider Alert actually ‘Alerted’ this recommendation to subscribers today?
All we really know is that the Teaser came out very recently, right?

I’m just wondering because the stock is +20% today on 2.5x volume. (and +5% after hours)
I would think that Subscriber Alerts would be, ordinarily, out of exact sync with Teasers.
Have non-Gumshoes decoded the teaser? Is Gumshoe-dom responsible for (some or much) of the stock blip?

Add a Topic
585
Add a Topic
5971
Add a Topic
5971
bill897
Member
bill897

If you have a product to sell and it’s use is off the charts, don’t you think this company will rocket, the hospitals will jump on this, the surgeons will answer. Hospitals that can’t afford De Vinci, can afford this and it will pay for itself in one year. The payback is tremendous. Hospitals are cheap. If its FDA approved, get it done. Get our surgeons going and trained. It will make us money. It’s a money maker. It’s got to hit big until TRXC comes out with Suribot 2. With a worldwide market for surgeries, we want to be… Read more »

Add a Topic
372
Add a Topic
3022
DrKSSMDPhD
Member

This is a good predictive call by Money Map. Since our original coverage of TransEnterix for the Biotech portion of Stock Gumshoe, the pot has sweetened considerably: smart hires, a powerhouse affiliation with an Italian robotics firm, crystallization of plans subsequently to pursue EU approval of Surgibot, insider acquisition of shares. I agree with Travis’s disquisition of the facts and particulars of the company. Disclosure: I am long $TRXC Disclosure: I know the founder of $TRXC but have not discussed the company with him. The founder is a serial medical inventor and entrepreneur, honest, competent, credible, and someone I have… Read more »

Add a Topic
605
Add a Topic
5971
Princess Dejah
Member
Princess Dejah

Thanks for the info!

Susan
Guest
Susan

So you stand behind what everyone every person at your company from Tom Gentile, Mike Ward Publisher of Energy Advantage, Dr Kent Moors, Shah Gilani who have been sending out emails blasts that the opportunity ends tonight ( over a period of a few days). With Mike Ward consistently standing behind this. It seems like the historic announcement is not imminent. Can you clarify because Money Map Press seems to be going overboard here. They didn’t do this with Dr Moore’s solar energy pitch. What is going on?

Add a Topic
4841
Add a Topic
1717
Add a Topic
1673
Serge Shammas
Guest
Serge Shammas

thanks

Quincy Adams
Guest
Quincy Adams

At today’s close, it’s priced at a modest 1300 times sales. Hope the devices work well with heart surgery…it’s investors may be needing it soon.

Mikael
Guest
Mikael

How can you value a pre-sales Company on a sales multiple? You have to look at the technology and the market size… With your thinking you could never invest in a technology or biotech company pre-sales…

xnlover
Guest
xnlover

Here is a link to Transenterix’s recent presentation that gives both the caveats regarding their prospects and the selling points of the product that is awaiting FDA approval. Comparing it with some of the other products for which links are provided below might help you make some decisions regarding investing in this one:
http://ir.transenterix.com/events.cfm
Note: I had to provide name, email, and “company,” for which I put “shareholder” and was given access to the slides.

Add a Topic
3022
mannydas
Member
mannydas

Is anyone familiar with “The Precision Profits System”, a Sovereign Society newsletter.
I received a promotion from them where they state “close out a gain of 100% (or more) … every month”. The promotion, a very long video, states, “Please Note: Since unveiling this system on November 17, we’ve closed out 5 more triple digit winners (104%, 100%, 101%, 207%, and 218%) “.
Cost: one-year membership is a mere $1,495!! Comes with 90 day money back guarantee.

Gr8Full!
Member

Stock Gumshoe is a much better deal at a mere 13 1/2 CENTS per day $49 annual Irregular membership – Best Investment I ever made 🙂 Best2You-Ben

Add a Topic
5971
Patricia
Member

Amen, Brother Ben. I feel the same.

Rusty Brown in Canada
Guest
Rusty Brown in Canada

Go ahead Travis. Take a bow. Don’t be bashful.

Opposeablethumb
Member

Well in only 3 months if they had invested their own money every dollar would be now worth 128. Why do they need 1495 when they have such awesome investments?
Think what that 1 dollar will grow to in ten years. Likely more than all the dollars in the universe.

Eric
Guest
Eric

“What I try to remind myself is that if the prospects are so phenomenal, then this will be a fine investment next year, and the year after that. Why not put off buying the stock until later when the company has established a record? Wait for the earnings. You can get tenbaggers in companies that have already proven themselves. When in doubt, tune in later”. Peter Lynch, One up On Wall Street, Chapter 9, page 159. Stocks i’d Avoid.

A hint to the wise is sufficient

Add a Topic
5971
Add a Topic
3949
Eric
Guest
Eric

Intuitive’s Da Vinci Dominates But Google To Challenge:
http://finance.yahoo.com/video/intuitives-da-vinci-dominates-google-154400982.html
Pay particular attention to the first minute or so of the video.

Add a Topic
372
Kevin
Guest
Kevin

Titan’s Sport ready roll strong in 2016!!!

Jim Leavenworth
Guest
Jim Leavenworth

Go Broncos! Awesome Dude!

suren123
Member
suren123

what is the company name ..?

Trish
Guest
Trish

Yes, I’d also like to know the name. For a subscription of close to $1500.00, that pays 2 months of my rent. I do not have currently that kind of money hanging around for a subscription that I more than likely will not read through. I don’t have a lot to invest, so money is precious to me. I would like to invest, earn some money and eventually get some bills paid down. I get annoyed when I click on a site like this and then have to listen to an hours worth of someone talking and they keep telling… Read more »

sergenet
Member
sergenet

Trish, when you get a video ad like the one in discussion here, just click on the x of the url to close the page and you will be presented with a choice to either stay on the page or leave. Select stay and then the video will disappear and a text content will replace it. You can scroll through it as you wish. the name of the stock is TRXC.

Add a Topic
5971
vicky
Guest
vicky

I listened to the entire video, my thoughts exactly!

sjanus11
Member
sjanus11

Trish, it’s TransEnterix, Inc. or ( TRXC)

arch1
Member

suren and Trish Transenterix is company name TRXC is symbol. You will find NO newsletter that gives better information than GS. $49.00 a year for irregulars. IMHO

Gr8Full!
Member

Stockgumshoe 13 1/2 Cents / day… incredible arth1 🙂

Vance
Guest
Vance

So, at what price will who short this one?
Maybe after one more strong run up day?

Add a Topic
899
Brian
Guest
Brian

Give me one more 20% upside day. I am shorting. Might be $20 down the line, but I will risk my personal dollars short term. $1.50 when the orchids come up in the Midwest. After that, buying long at the price when the promotion hit. It’s worked for me. Time after time after time. Thank you Travis. Thank you KSS. Thank you all. Your knowledge humbles me.

Add a Topic
1278
A